Cirrhosis leads to sarcopenia and functional decline that can severely impact one's ability to function at home and in society. Self-reported disability scales to quantify disability-Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL)-are validated to predict mortality in older adults. To evaluate disability in liver transplantation (LT) candidates and quantify its impact on outcomes, consecutive outpatients 18 years listed for LT with laboratory Model for End-Stage Liver Disease scores of 12 at a single high-volume US LT center were assessed for ADLs and IADLs during clinic visits. Multivariate competing risk models explored the effect of disabilities on wait-list mortality (death or delisting for illness). Of 458 patients, 36% were women, median (interquartile range [IQR]) age was 60 years (IQR, 54-64 years), and initial Model for EndStage Liver Disease-Sodium (MELD-Na) was 17 (IQR 14-20). At first visit, 31% had lost 1 ADL, and 40% had lost 1 IADL. The most prevalent ADL deficits lost were continence (22%), dressing (12%), and transferring (11%); the most prevalent IADLs lost were shopping (28%), food preparation (23%), and medication management (22%). After adjustment for age, MELD-Na, and encephalopathy, dressing (subdistribution hazard ratio [SHR], 1.7; 95% confidence interval [CI], 1.0-2.8; P 5 0.04), toileting (SHR, 1.9; 95% CI, 1.1-3.5; P 5 0.03), transferring (SHR, 1.9; 95% CI, 1.1-3.0; P 5 0.009), housekeeping (SHR, 1.8; 95% CI, 1.2-3.0; P 5 0.009), and laundry (SHR, 2.2; 95% CI, 1.3-3.5; P 5 0.002) remained independent predictors of wait-list mortality. In conclusion, ADL/IADL deficits are common in LT candidates. LT candidates would benefit from chronic disease management programs developed to address the impact of cirrhosis on their daily lives.
Patients with cirrhosis experience premature and accelerated physiologic aging. (1, 2) Although end-stage liver disease frequently develops well before the age of 65 years in individuals with underlying chronic liver disease, patients with cirrhosis often suffer from common geriatric conditions such as functional decline, polypharmacy, and cognitive impairment, all of which contribute to a high risk of physical disability. (3, 4) The Activities of Daily Living (ADL) represent the domains of function that a person must be able to manage in order to live independently. Disability in ADL and Instrumental Activities of Daily Living (IADL) often develops in older age, but patients with chronic illness are often disabled earlier. In cirrhosis, just as in older age, the need for help with these activities suggests a severity of cirrhosis that threatens independent living. In other longterm conditions such as heart failure, chronic disease management programs engaging in patient education and medication management have been effective at reducing the burden of disabling symptoms of chronic disease. (5, 6) Disease management programs for liver failure also have emerged as promising tools for improving quality of Abbreviations: ADL, Activities of Daily Living; BMI, body mass index; CI, confidence interval; FrAILT, Functional Assessment in Liver Transplantation; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; IADL, Instrumental Activities of Daily Living; INR, international normalized ratio; IQR, interquartile range; LT, liver transplantation; MELD, Model for EndStage Liver Disease; MELD-Na, Model for End-Stage Liver Disease-Sodium; NASH, nonalcoholic steatohepatitis; PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis; SHR, subdistribution hazard ratio.
life. (7) However, little is known of specific domains in which patients with end-stage liver disease experience disability. Understanding how patients with cirrhosis are disabled would enable us to better develop interventions to improve their quality of life.
As has been demonstrated in older adults and select surgical and inpatient populations-including patients with cirrhosis hospitalized for hepatic decompensation-disability is also a well-established predictor of mortality. (8) (9) (10) (11) This is even more critical for a patient awaiting liver transplantation (LT), for whom it is particularly important to determine whether the disability is expected to reverse after transplantation.
Therefore, in this study, we aimed to fully characterize disability in patients with cirrhosis on the LT waiting list, to isolate predictors of subsequent disability, and to identify individual disabilities associated with poor outcomes.
Patients and Methods
The Functional Assessment in Liver Transplantation (FrAILT) Study, initiated in July 2012, is an ongoing prospective, longitudinal cohort of adults (18 years) with cirrhosis listed for LT with a Model for EndStage Liver Disease (MELD) score 12 at a single high-volume LT center. Patients were included if they had at least 2 visits in the study. Excluded were patients with severe hepatic encephalopathy (>120 seconds on the Numbers Connection Test) due to potential difficulty in following study procedures.
At enrollment and at every subsequent clinic visit, we assessed disability in every study participant using 2 validated scales. For ADL, (12) study staff asked "Do you have difficulty with ___?"; for IADL, (13) study staff asked "Are you able to ___?", with follow-up questions to determine the degree of disability if indicated. Individuals were considered to have lost an ADL/IADL ability if they were unable to perform the minimum activity criteria detailed in Table 1 . Disabilities were analyzed as individual categorical variables.
Laboratory tests were collected from the patient's electronic health record at the time of each visit. Hepatic encephalopathy was classified based on performance on the Numbers Connection Test Score, as none/mild (60 seconds) and moderate/severe (>60 seconds). Race was dichotomized as white/nonwhite for statistical modeling. Frailty was assessed at each visit using a previously described 3-level score combining objective weight loss, grip strength, walk speed, and self-reported activity level and exhaustion (gets clothes or dresses without assistance, except for tying shoes.) 3. Toileting-"Have you had difficulty using the toilet in the last two weeks?" (goes to toilet room, uses toilet, arranges clothes, and returns without assistance. May use cane/walker and bedpan/urinal at night.) 4. Transferring-"Have you had difficulty transferring in the last two weeks?" (moves in and out of bed and chair without assistance, may use cane/walker.) 5. Continence-"Have you had any accidents before you've reached the restroom in the last two weeks?" (controls bowel and bladder completely by self.) 6. Feeding-"Have you had difficulty feeding yourself in the last two weeks?" (feeds self without assistance except for help with cutting meat or buttering bread.) IADL 1. Telephone-"Are you able to answer the telephone?" (answers telephone.) 2. Shopping-"Are you able to shop independently?" (takes care of all shopping needs independently.) 3. Food preparation-"Are you able to prepare your own food?" (plans, prepares, and serves adequate meals independently.) 4. Housekeeping-"Are you able to do housekeeping?" (participates in some housekeeping tasks.) 5. Laundry-"Are you able to do your own laundry?" (launders at least small items.) 6. Transportation-"Are you able to arrange your own transportation?" (arranges own travel by car/taxi, may be accompanied by another on public transit.) 7. Medication management-"Are you able to manage your own medications?" (is responsible for taking correct dosage of medication at correct times.) 8. Finances-"Are you able to manage your finances?" (manages day-today purchases, may receive assistance with banking.)
measures. (14) Lactulose use was collected from the medication list at the initial study visit.
STATISTICAL ANALYSIS
Differences in baseline characteristics by presence of disability at first visit were compared using chi-square test for categorical variables and paired t test for continuous variables. Initial disability on the waiting list was described in the subset of patients with no disabilities at first visit.
Competing risks regression (15) evaluated the effect of time-varying ADL and IADL disabilities on waitlist mortality, defined as death or delisting for being too sick for transplant, with transplant as a competing risk. Patients were censored when delisted for other reasons. Multivariate models initially included age, presence of hepatocellular carcinoma (HCC), and indicators of liver disease status: Model for End-Stage Liver Disease-Sodium (MELD-Na), albumin, ascites, and encephalopathy. To improve precision, backward stepwise selection was used to trim models to predictors with P < 0.1. A more conservative cutoff of P < 0.1 was used to reduce the possibility of residual confounding with a relatively small number of outcomes. Final multivariate models were adjusted for age, MELD-Na, and hepatic encephalopathy. A similar analysis evaluated the contribution of the total number of disabilities.
Competing risks regression also evaluated the predictors of new or subsequent disability, with transplant and wait-list mortality as competing risks. Backward stepwise selection was used to select predictors with P < 0.1.
The University of California, San Francisco institutional review board approved this study. All statistical analyses were performed using STATA, version 13 (StataCorp LP, College Station, TX).
Results

BASELINE PATIENT CHARACTERISTICS
For this study, 469 patients were included, whose baseline characteristics are shown in Table 2 . Median 
PHYSICAL DISABILITY IN THE COHORT
At their first visit, 31% reported difficulty with 1 ADL; 40% needed help with 1 IADL. Patients reporting difficulty with at least 1 ADL or IADL (n 5 224) were more likely to be men, more likely to have a higher body mass index (BMI), higher MELDNa, more ascites, more likely to be encephalopathic, and less likely to have HCC.
The most prevalent ADL disabilities at the initial visit were continence (20%), dressing (9%), and transferring (9%); the most prevalent IADL disabilities were shopping (24%), food preparation (20%), and management of medications (17%). At their first study visit, 55% of patients were on lactulose. Patients on lactulose were more likely to be incontinent (26% versus 14%; P 5 0.001).
Over time, 125 (27%) of those who did not report any disabilities at baseline developed difficulty with at least 1 ADL; 127 (28%) reported difficulty with at least 1 IADL. The most frequent first ADL disabilities were transferring and continence; the most frequent first IADL disabilities lost were shopping and food preparation (Fig. 1) .
Baseline disability, male sex, higher MELD-Na, ascites, and frailty were predictive of new or increasing IADL disability. Men had 1.6 (95% confidence interval [CI], 1.2-2.2; P 5 0.004) times the hazard of subsequent disability compared with women. Baseline disability and higher BMI were independently predictive of subsequent ADL disability. Each additional ADL disability at baseline was associated with 1.8 (95% CI, 1.4-2.4; P < 0.001) times the hazard of new ADL disabilities (Table 3) . Neither sex, MELD-Na, nor frailty was predictive of subsequent ADL disability.
PHYSICAL DISABILITY AND WAIT-LIST OUTCOME
By the end of follow-up, 33% of patients received a transplant, 18% died or were delisted due to illness, and 39% were still waiting.
On univariate competing risks regression, almost all ADL/IADL disabilities were significantly associated with wait-list mortality. After adjustment for age, MELD-Na, frailty, and hepatic encephalopathy, difficulty dressing (subdistribution hazard ratio [SHR], 1.7; 95% CI, 1.0-2.8; P 5 0.04), difficulty toileting (SHR, 1.9; 95% CI, 1.1-3.5; P 5 0.03), transferring (SHR, 1.9; 95% CI, 1.1-3.0; P 5 0.009), needing help with housekeeping (SHR, 1.8; 95% CI, 1.2-3.0; P 5 0.009), and laundry (SHR, 2.2; 95% CI, 1.3-3.5; P 5 0.002) remained independent predictors of waitlist mortality (Table 4) . After adjusting for MELDNa, hepatic encephalopathy, age, frailty, and lactulose use, incontinence was associated with an increased hazard of wait-list mortality (SHR, 1.9; 95% CI, 1.1-3.2; P 5 0.02).
Discussion
Much of the management of liver disease focuses on helping patients manage the physiologic derangements caused by cirrhosis. The measurement of self-reported ADL and IADL disability has not traditionally been a part of the clinical assessment of cirrhosis, but it conveys crucial information beyond that found in laboratory values and performance-based frailty metrics. For a patient with decompensated cirrhosis, disability reflects the accumulation of deficits from not only portal hypertension and sarcopenia, but also malnutrition, coronary artery disease, and depression (among many other conditions). Although related to frailty-ie, a frail individual is more likely to experience disabilitydisability tells us how an individual's frailty impacts his or her day-to-day activities. By describing the specific ways in which a patient cannot complete his daily activities, the ADL/IADL scales are, in a way, the most patient-oriented outcomes that we can measure in our clinical practice. How better and more directly can we address our patients' daily unmet needs than by asking the ways in which they cannot function at home and within their communities? In this outpatient cohort of patients with cirrhosis awaiting LT, more than half are not able to do at least 1 basic activity necessary for functioning within the home or in society. Despite 75% being under 65 years of age, patients with cirrhosis suffer more functional disability than adults 80 years of age and older. (16) Prevalent disability was the strongest risk factor for subsequent disability, and over half of our cohort experienced new or increasing ADL and IADL disability during their time on the waiting list. This rate far outstrips age-related loss of ability, which at this age range is expected to increase by less than 10% per decade. (17) We particularly emphasize the high prevalence of incontinence in our cohort. At 26% among lactulose users, it is as common in our patients with cirrhosis as is fecal incontinence in patients who have suffered a stroke. (18) Fecal incontinence can lead to embarrassment, social isolation, loss of self-esteem, and loss of employment. (19) (20) (21) Despite the impact of incontinence on daily life, most patients do not volunteer this information unless the provider explicitly inquires. (22) (23) (24) We suggest that providers should inquire about what is essentially an iatrogenic disability.
With this information, we can begin to develop mechanisms of addressing our patients' daily disabilities. Incontinence is a problem familiar to the gastroenterologist, with an armamentarium of conservative management tools. (25) Simple interventions such as barrier creams, absorptive products, and bowel training can reduce the impact of incontinence on quality of life with minimal provider time investment. (26, 27) Intensive education regarding titration of the dosage and timing of lactulose-and use of adjunctive therapies (eg, rifaximin, probiotics, zinc) to enhance control of hepatic encephalopathy-could offer significant benefits through reduction of incontinence and increased adherence to therapy. Finding that 17% of our cohort are dependent in medication management reminds the clinician to involve caregivers and clinic pharmacists in this discussion.
In congestive heart failure, comprehensive disease management programs have become a class 1 recommendation in practice guidelines. (28) Similar programs for end-stage liver disease may have their greatest impact in standardizing implementation of practice guidelines (29) and increasing patient understanding of complex plans of care, (30) and have already been successful in reducing preprocedure and periadmission mortality. (31, 32) They may also have the potential to greatly improve our patients' quality of life. Perhaps even more importantly, screening for disability can help us identify those who are at greatest risk for subsequent disability, and therefore, in greatest need of such chronic disease management programs.
We acknowledge several limitations to this study. This study did not account for intervening hospitalizations, which likely contributed to subsequent disability (as has been previously demonstrated in older adults without chronic liver disease), (33) and should be evaluated in future studies as both a predictor and a result of disability. Inclusion of only outpatients with MELD scores 12 limits this study's generalizability to the LT population as a whole, but we suspect that patients with MELD scores <12 have much lower rates of disability and would have contributed relatively few waitlist events to our analyses. Finally, despite enrolling most of the LT waiting list at one of the largest transplant centers in the nation over a period of 6 years, we do not presently have enough posttransplant outcomes to evaluate disability as a modifiable risk factor for posttransplant outcomes. We anticipate addressing this question in the future.
Despite these limitations, this study demonstrates the high overall prevalence of disability on the LT waiting list and identifies the specific areas in which LT candidates are disabled. These data underscore the importance of developing chronic disease management programs to help address the many ways in which cirrhosis impacts individuals' lives-beyond ascites and varices. We advocate for the routine assessment of disability using these simple, low-cost disability scales to identify those in greatest need of integrated disease management programs and simple interventions. These data are a crucial step toward future work addressing posttransplant outcomes, including disability resolution.
